期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
妊娠期肝内胆汁淤积症血清甘胆酸水平对围生儿及孕妇影响 被引量:12
1
作者 巩海亮 《中国医药导报》 CAS 2014年第9期74-76,共3页
目的 观察妊娠期肝内胆汁淤积症(ICP)孕妇及胎儿结局,分析影响因素.方法 回顾性分析2009年3月~2011年6月河北省邯郸明仁医院ICP孕妇130例为观察组,选择同期无ICP孕妇150例为对照组,检测并比较两组孕妇终止妊娠前血清甘胆酸水平,观察... 目的 观察妊娠期肝内胆汁淤积症(ICP)孕妇及胎儿结局,分析影响因素.方法 回顾性分析2009年3月~2011年6月河北省邯郸明仁医院ICP孕妇130例为观察组,选择同期无ICP孕妇150例为对照组,检测并比较两组孕妇终止妊娠前血清甘胆酸水平,观察并比较两组产妇产后出血情况、新生儿分娩方式以及产后新生儿窘迫、新生儿窒息等胎儿预后情况.结果 观察组血清甘胆酸水平[(1872.5±837.5)μg/dL]明显高于对照组[(137.6±79.3) μg/dL],差异有高度统计学意义(t=4.27,P<0.01).观察组胎儿窘迫、新生儿窒息、早产发生率(44.6%、18.5%、20.8%)均高于对照组(15.3%、6.0%、l2.7%),差异均有统计学意义(x2=16.673、6.715、4.146;P=0.002、0.001、0.015);观察组产妇分娩时大出血(≥400 mL)、胎死宫内发生率(22.3%、3.8%)与对照组(12.0%、1.3%)相比较,差异均无统计学意义(x2=1.179、3.436;P=0.053、0.051).随着血清甘胆酸水平升高,胎儿窘迫、胎儿窒息、早产发生率升高.结论 ICP对孕妇及胎儿均存在不良影响,对新生儿影响更大,且随着孕妇血清甘胆酸水平升高,新生儿预后愈差.临床上,对ICP患者应加强监测,及早采取干预措施. 展开更多
关键词 胆法淤积 新生儿预后 产后出血
下载PDF
血氨基酸异常婴儿肝内胆汁淤积症患者SLC25A13基因的突变谱 被引量:6
2
作者 张绍仁 王建设 +2 位作者 王晓红 朱启镕 刘丽艳 《中华肝脏病杂志》 CAS CSCD 北大核心 2008年第6期445-448,共4页
目的探讨血氨基酸异常婴儿肝内胆汁淤积症中是否存在SLC25A13基因突变及其突变谱特征。方法对2003年6月2007年6月就诊于复旦大学附属儿科医院的不明原因婴儿肝内胆汁淤积症患儿进行血氨基酸质谱分析,将检测有瓜氨酸、蛋氨酸至少一项2... 目的探讨血氨基酸异常婴儿肝内胆汁淤积症中是否存在SLC25A13基因突变及其突变谱特征。方法对2003年6月2007年6月就诊于复旦大学附属儿科医院的不明原因婴儿肝内胆汁淤积症患儿进行血氨基酸质谱分析,将检测有瓜氨酸、蛋氨酸至少一项2倍以上升高者共14例进行基因研究。全部入选对象先行SLC25A13基因的12种突变位点([I]851del4、[Ⅱ]IVS11+1G〉A、[Ⅲ]1638ins23、[Ⅳ]S225X、[V]IVS13+1G〉A、[Ⅵ]1800ins1、[Ⅶ]R605X、[Ⅷ]E601X、[Ⅸ]E601K、[Ⅹ]IVS6+5G〉A、[Ⅺ]R184X及[ⅩⅣ]IVS6+1G〉C)的检测。对仅检出单个位点突变的研究对象,继续进行所有外娃子区及其邻近序列分析。结果检出SLC25A13基因突变8例,包括复合杂合突变851de14/1638ins232例,纯合突变851de14/851del4、复合杂合突变851del4/R184X及纯合突变IVS6+1G〉A/IVS6+1G〉各1例,杂合突变851del43例,其中纯合突变IVS6+1G〉A/IVS6+1G〉A是一种新型突变。结论血氨基酸异常婴儿肝内胆汁淤积症中存在SLC25AI3基因突变。[I]851del4、[Ⅲ]1638ins23是中国SLC25A13基因的常见突变形式,新发现1例纯合突变IVS6+1G〉A/IVS6+1G〉A,和国外报道突变谱存在明显区别。 展开更多
关键词 胆法淤积 肝内 婴儿 突变 SLC25A13基因
原文传递
Comparison of different diagnostic methods in infants with Cholestasis 被引量:15
3
作者 Seyed Mohsen Dehghani Mahmood Haghighat +1 位作者 Mohammad Hadi Imanieh Bita Geramizadeh 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第36期5893-5896,共4页
AIM: To evaluate different methods in differentiating idiopathic neonatal hepatitis from biliary atresia. METHODS: Sixty-five infants with cholestatic jaundice and final diagnosis of idiopathic neonatal hepatitis and ... AIM: To evaluate different methods in differentiating idiopathic neonatal hepatitis from biliary atresia. METHODS: Sixty-five infants with cholestatic jaundice and final diagnosis of idiopathic neonatal hepatitis and biliary atresia were studied prospectively from September 2003 to March 2006. A thorough history and physical examination were undertaken and the liver enzymes were examined. All cases underwent abdominal ultrasonography, hepatobiliary scintigraphy, and percutaneous liver biopsy. The accuracy, sensitivity, specificity and predictive values of these various methods were compared. RESULTS: There were 34 girls and 31 boys, among them 46 subjects had idiopathic neonatal hepatitis (age, 61 ± 17 d) and 19 had biliary atresia (age, 64 ± 18 d). The mean age at onset of jaundice was significantly lower in cases of biliary atresia when compared to idiopathic neonatal hepatitis cases (9 ± 13 d vs 20 ± 21 d; P = 0.032). The diagnostic accuracy of different methods was as follows: liver biopsy, 96.9%; clinical evaluation, 70.8%; ultrasonography, 69.2%; hepatobiliary scintigraphy, 58.5%; and liver enzymes, 50.8%.CONCLUSION: Our results indicate that clinical evaluation by an experienced pediatric hepatologist and a biopsy of the liver are considered as the most reliable methods to differentiate idiopathic neonatal hepatitis and biliary atresia. 展开更多
关键词 Idiopathic neonatal hepatitis Biliary atresia Clinical evaluation Liver biopsy
下载PDF
Why more attentions to fetus in cases of intrahepatic cholestasis of pregnancy?
4
作者 Xiu-Quan Zhang Yi-Lin Ding Li-Juan Zhang 《World Journal of Obstetrics and Gynecology》 2013年第4期62-64,共3页
Intrahepatic cholestasis of pregnancy(ICP) is a peculiar disease in middle-late pregnancy with the pathological characteristics of hepatic capillary bile duct silts and is accompanied by clinical presentations of prur... Intrahepatic cholestasis of pregnancy(ICP) is a peculiar disease in middle-late pregnancy with the pathological characteristics of hepatic capillary bile duct silts and is accompanied by clinical presentations of pruritus and bile acid(BA) elevation in serum. Maternal outcomes for patients diagnosed with ICP are usually good. However, fetal outcomes can be devastating with high frequencies of perinatal complications. Patients with ICP generally have an early delivery due to fetal complications. The current hypothesis is that ICP has higher frequencies of fetal complications due to high concentrations of BA which has toxic cellular effects to many organs. In lungs, it destroys the AT-II cells, decreasing phospholipids synthesis leading to the alveolar capillary permeability to increase and pulmonary surfactant to decrease. In heart, cholate can cross into the fetal compartment and causing fetal arrhythmias and decreased contractility. In the nervous system, high BAs can cause nerve cell denaturation and necrosis, mitochondria edema and membrane dissolve. In the placenta, high BA concentration can cause edema of the villous, decrease number of villous, intervillous thickening and balloon formation.In addition, high total BA can result in chorionic vein constriction and impaired fetal adrenal function. 展开更多
关键词 Intrahepatic cholestasis of pregnancy Bile acid Perinatal outcome Fetal lung Fetal heart
下载PDF
Drug-induced liver injury due to “natural products” used for weight loss:A case report 被引量:2
5
作者 Giovanni Tarantino Martina Gilda Pezzullo +4 位作者 Matteo Nicola Dario di Minno Francesco Milone Luigi Sossio Pezzullo Marco Milone Domenico Capone 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第19期2414-2417,共4页
Taking herbal-extracts to lose weight is an underestimated health hazard.Often,these products contain active agents that can cause acute liver damage.In this case report,a 22-year-old female patient,who presented with... Taking herbal-extracts to lose weight is an underestimated health hazard.Often,these products contain active agents that can cause acute liver damage.In this case report,a 22-year-old female patient,who presented with a feature of cholestatic syndrome,was so sure that the "natural products" were not dangerous that she did not inform her physicians that she had taken them,making their task that much more challenging.Clinical presentation mimicked acute cholecystitis and the patient underwent a cholecystectomy.Surgery was without any consequences and complications,although it did not completely cure the illness.She later admitted to having taken herbal remedies and this led to the correct diagnosis of phytotherapy-related hepatotoxicity and a successful therapeutic approach.The true incidence of phytotherapy-related hepatotoxicity and its pathogenic mechanisms are largely unknown.It is important to increase the awareness of both clinicians and patients about the potential dangers of herbal remedies. 展开更多
关键词 Drug-induced liver injury OBESITY Herbalremedies CHOLECYSTITIS
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部